U.S., April 5 -- ClinicalTrials.gov registry received information related to the study (NCT06911034) titled 'Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women' on March 28.
Brief Summary: This clinical trial aimed to determine whether intravenous ferric carboxymaltose is more useful than iron sucrose for treating anemia in pregnant women.
The main question it aimed to answer was:
Is intravenous ferric carboxymaltose is more useful than iron sucrose for treating iron deficiency anemia in pregnant women.
Sixty pregnant women with iron deficiency anemia were enrolled to one of two intravenous treatments.
* Participants in ferrous carboxymaltose group received a maximum dose of 1000 mg per sitting diluted in 2...